These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19700066)

  • 41. CCR2 inhibition: a panacea for diabetic kidney disease?
    Weir MR
    Lancet Diabetes Endocrinol; 2015 Sep; 3(9):666-7. PubMed ID: 26268909
    [No Abstract]   [Full Text] [Related]  

  • 42. [Diabetic nephropathy. A matter of inflammation?].
    Navarro J
    Nefrologia; 2003; 23(5):381-9. PubMed ID: 14658163
    [No Abstract]   [Full Text] [Related]  

  • 43. American Diabetes Association Annual Meeting, 1998. Nephropathy and retinopathy.
    Bloomgarden ZT
    Diabetes Care; 1999 Apr; 22(4):640-4. PubMed ID: 10189545
    [No Abstract]   [Full Text] [Related]  

  • 44. Diabetes and the kidney in pregnancy.
    Powe CE; Thadhani R
    Semin Nephrol; 2011 Jan; 31(1):59-69. PubMed ID: 21266265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Indication of vitamin E on microalbuminuria in patients with incipient diabetic nephropathy.
    Yokoyama M; Torita M; Yoshizawa M; Usuda R
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):611-2. PubMed ID: 11694862
    [No Abstract]   [Full Text] [Related]  

  • 46. Obesity, diabetes, adiponectin and the kidney: a podocyte affair.
    Zoccali C; Mallamaci F
    Nephrol Dial Transplant; 2008 Dec; 23(12):3767-70. PubMed ID: 18802210
    [No Abstract]   [Full Text] [Related]  

  • 47. TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes.
    Joshi D; Gupta R; Dubey A; Shiwalkar A; Pathak P; Gupta RC; Chauthaiwale V; Dutt C
    J Cardiovasc Pharmacol; 2009 Jul; 54(1):72-81. PubMed ID: 19546815
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin II receptor antagonism in diabetic nephropathy.
    Hollis S
    Diabet Med; 2002 Jun; 19 Suppl 3():10; discussion 10-1. PubMed ID: 12030860
    [No Abstract]   [Full Text] [Related]  

  • 49. Renal segmental hypoplasia, Ask-Upmark kidney, in a patient with microalbuminuric hypertensive type 2 diabetes mellitus.
    Fuke T; Sugimoto T; Ugi S; Omura Y; Nishio Y; Maegawa H; Kashiwagi A
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e22-4. PubMed ID: 18178284
    [No Abstract]   [Full Text] [Related]  

  • 50. Podocyte loss and progression of diabetic nephropathy.
    Shirato I; Hishiki T; Tomino Y
    Contrib Nephrol; 2001; (134):69-73. PubMed ID: 11665290
    [No Abstract]   [Full Text] [Related]  

  • 51. Combine and Conquer: With Type 2 Diabetes Polypharmacy Is Essential Not Only to Achieve Glycemic Control but Also to Treat the Comorbidities and Stabilize or Slow the Advancement of Diabetic Nephropathy.
    Bell DSH
    J Diabetes Res; 2022; 2022():7787732. PubMed ID: 35967126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An evaluation of renal biopsy in type-II diabetic patients.
    Arif M; Arif MK; Arif MS
    J Coll Physicians Surg Pak; 2009 Oct; 19(10):627-31. PubMed ID: 19811713
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disseminated Mycobacterium marinum infection in a patient with diabetic nephropathy.
    Imakado S; Kojima Y; Hiyoshi T; Morimoto S
    Diabetes Res Clin Pract; 2009 Feb; 83(2):e35-6. PubMed ID: 19108924
    [No Abstract]   [Full Text] [Related]  

  • 54. Accounting for Missing Data in Clinical Research.
    Stevens JR; Suyundikov A; Slattery ML
    JAMA; 2016 Feb; 315(5):517-8. PubMed ID: 26836740
    [No Abstract]   [Full Text] [Related]  

  • 55. Early functional and morphologic vascular renal consequences of the diabetic state.
    Viberti GC; Haycock GB; Pickup JC; Jarrett RJ; Keen H
    Diabetologia; 1980; 18(2):173-7. PubMed ID: 6988278
    [No Abstract]   [Full Text] [Related]  

  • 56. Decreased albuminuria by pravastatin in hyperlipidemic diabetics.
    Shoji T; Nishizawa Y; Toyokawa A; Kawagishi T; Okuno Y; Morii H
    Nephron; 1991; 59(4):664-5. PubMed ID: 1766510
    [No Abstract]   [Full Text] [Related]  

  • 57. [Interview with professor Thierry Hannedouche].
    Hannedouche T
    Nephrol Ther; 2006 May; 2 Suppl 3():S200-2. PubMed ID: 17370852
    [No Abstract]   [Full Text] [Related]  

  • 58. Multifactorial acute renal failure treated with percutaneous targeted renal therapy (TRT): a case of "dialysis rescue".
    Allie DE; Hebert CJ; Walker CM
    J Invasive Cardiol; 2007 Feb; 19(2):E27-30. PubMed ID: 17268046
    [No Abstract]   [Full Text] [Related]  

  • 59. Accounting for Missing Data in Clinical Research--Reply.
    Newgard CD; Lewis RJ
    JAMA; 2016 Feb; 315(5):518. PubMed ID: 26836743
    [No Abstract]   [Full Text] [Related]  

  • 60. [Criteria of adequate use of nitroglycerin and dopamine in patients with myocardial infarct in relation to the renal state].
    Tikhonov VP; Solomatin VA
    Klin Med (Mosk); 1995; 73(5):75. PubMed ID: 8815295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.